The second registered study, REDEFINE, is a phase 3 trial evaluating the combination therapy of cagrilintide and semaglutide, known as CagriSema, to achieve weight loss in people with excess body weight and T2D
G9200, G9201, G9202 Caspase-Glo 3/7 Assay System An easy-to-use, plate-based luminescent assay for detecting caspase-3/7 activity
Available in 5mg & 10mg vials, independently verified 99% purity
Biochem J 307:697705 Meister A, Anderson ME (1983) Glutathione Ann Rev Biochem 52:711760 Mendoza-Cozatl DG, Jobe TO, Hauser F, Schroeder JL (2011) Long-distance transport, vacuolar sequestration, tolerance, and transcriptional responses induced by cadmium and arsenic
Book Now Achieve powerful weight loss and metabolic improvements with Retatrutide 20 mg advanced triple-agonist peptide therapy